Diagnostics, Risk Factors, and Management of Diabetic Neuropathy
DOI:
https://doi.org/10.53089/medula.v13i1.555Keywords:
Keywords: diabetic neuropathy; diagnose; management; prevalence; risk factorAbstract
Diabetic neuropathy is the most common complication of diabetes mellitus. As many 25% of people with diabetes mellitus in the world and 54% in Indonesia suffer from diabetic neuropathy. Electro-diagnostic studies are best used for the diagnosis of diabetic neuropathy. In addition, the diagnosis can be made by scoring Diabetic Neuropathy Symptom (DNS) and Diabetic Neuropathy Examination (DNE). Patients with diabetes mellitus must pay attention to risk factors such as carbohydrate intake, physical activity, duration of suffering, and medication adherence to prevent complications of diabetic neuropathy. Management of diabetic neuropathy can be done with drugs or other supportive therapy. This article uses a literature review method from various national and international journal references with the following search keywords: prevalence, diagnosis, risk factors, and management of diabetic neuropathy.
References
Suyono S, et al. Penatalaksanaan Diabetes Melitus Terpadu: Panduan Penatalaksanaan Diabetes Melitus Bagi Dokter Dan Edukator. Edisi 2. Jakarta: Balai Penerbit FKUI. 2018.
Tjandrawinata RR. Patogenesis Diabetes Tipe 2: Resistensi Defisiensi Insulin. Tangerang: Dexa Medica. 2016.
Alleman CJM, Westerhout KY, Hensen M, Chambers C, Stoker M, Long S, et. al. Humanistic and Economic Burden of Painful Diabetic Peripheral Neuropathy in Europe. Diabetes Research and Clinical Practice. 2015;109(2):215-225
Hoke A, Smith G, Freeman R, Simpson D, Driss SA. Foundation for Peripheral Neuropathy International Research Symposium: Advances in Neuropathy-Emerging Disease. Journal of the Peripheral Nervous System. 2017;0(0):1-24.
Infodatin. Situasi dan Analisis Diabetes. Jakarta Selatan: Pusat Data dan Informasi Kementerian Kesehatan Republik Indonesia. 2014.
Prasetyo MA. Pengaruh Pemberian Alpha Lipoic Acid Terhadap Perbaikan Klinis Polineuropati Diabetika. Semarang: Bagian Saraf RS. Dr. Kariadi Semarang. 2011.
Asad A, Hameed MA, Khan UA, Butt MRA, Ahmed N, Nadeem A. Comparison of Nerve Conduction Studies with Diabetic Neuropathy Symptom Score and Diabetic Neuropathy Examination Score in Type 2 Diabetics for detection Of Sensorimotor Polyneuropathy. Journal of the Pakistan Medical Association. 2009;59(9):594-8.
Meijer JWK, Bosma E, Lefrandt JD, Links TP, Smit AJ, Stewart RE, et al. Clinical Diagnosis of Diabetic Neuropathy Symptom and Diabetic Neuropathy Examination Scores. American Diabetes Association. 2003;23(3):691-701.
Choi JM, Maria GD. Electrodiagnostic Testing for Disorders of Peripheral Nerves. Elsevier. 2021;37:2019-221.
Putri RN, Waluyo A. Faktor Risiko Neuropati Perifer Diabetik Pada Pasien Diabetes Melitus Tipe 2. Jurnal Keperawatan. 2020;3(2):17-25.
Fitri RI, Yekti W. Hubungan Konsumsi Karbohidrat, Konsumsi Total Energi, Konsumsi Serat, Beban Glikemik dan Latihan Jasmani Dengan Kadar Glukosa Darah Pada Pasien Diabetes Mellitus Tipe 2. Journal Nutrition and Health. 2014;2(3):1-27.
Widiastuti NH. Faktor Risiko yang Mempengaruhi Terjadinya Resistensi Insulin Pada Wanita Lansia 58-65 Tahun di Komunitas Lansia Restu RSUD dr. Soetemo Surabaya [Tesis]. Surabaya: Universitas Airlangga. 2019.
American Diabetes Association. Classication and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care. 2019;42(1):13-28.
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 41 Tahun 2014 tentang pedoman gizi seimbang. Jakarta: Permenkes RI. 2014.
Badrujamaludin A, Santoso MB, Nastrya D. Hubungan Aktivitas Fisik dengan Kejadian Neuropati Diabetik Pada Penderita Diabetes Melitus Tipe 2. Holistik Jurnal Kesehatan. 2021;15(2):176-186.
Canadian Diabetes Association. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes. 2008;32(1):37-8.
Al-Attaby AKT, Al-Lami MQD. Effects of Duration and Complications of Type 2 Diabetes Mellitus on Diabetic Related Parametes, Adipocytokines and Calcium Regulating Hormones. Iraqi Journal of Science. 2019;60(11):2353-61.
Simanjuntak GV, Simamora M. Lama Menderita Diabetes Melitus Tipe 2 Sebagai Faktor Risiko Neuropati Perifer Diabetik. Holistik Jurnal Kesehatan. 2020;14(1):96-100.
Setyadi A. Perbedaan kadar zink serum pasien diabetes melitus dengan neuropati dan tanpa neuropati [karya tulis ilmiah]. Semarang: Universitas Diponegoro. 2017.
Rosyida L, Priyandani Y, Sulistyarini A, Nita Y. Kepatuhan Pasien Pada Penggunaan Obat Antidiabetes dengan Metode Pill-Count dan mmas-8 di Puskesmas Kedurus Surabaya. Jurnal Farmasi Komunitas. 2015;2(2):36-41.
Fandinata SS, Darmawan R. Pengaruh Kepatuhan Minum Obat Oral Antidiabetik Terhadap Kadar Gula Darah Pasien Diabetes Mellitus Tipe II. Jurnal Bidang Ilmu Kesehatan. 10(1): 23-31.
Ramadona A. Hubungan Kepatuhan Minum Obat dengan Munculnya Gejala Neuropati Pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Andalas [Skripsi]. Padang: Universitas Andalas. 2021.
Nanda DO, Wiryanto BR, Triyono AE. Hubungan kepatuhan minum obat antidiabetik dengan regulasi kadar gula darah pada pasien perempuan diabetes melitus. E-Journal UNAIR Amerta Nutr. 2018;340-348.
Purwata ITE. Pain Education Edisi 1. Medan: Pustaka Bangsa Press; 2017.
Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral Neuropathy: Differential Diagnosis and Management. American Family Physician. 2010;81(7):887-892.
Rachmantoko R, Afif Z, Rahmawati D, Rakhmatiar R, Kurniawan SN. Diabetic Neuropathic Pain. Journal of Pain Headache and Vertigo. 2021;14(2):276-282.
Devi FL. Manajemen Nyeri Neuropatik. Jurnal Penelitian Perawat Profesional. 2021;3(1):179-188.
Pebrianti S, Nugraha BA, Shallahudin I. Manajemen Nyeri Neuropati Pada Pasien Diabetes Melitus Tipe 2: Studi Literatur. 2020;14(2):276-282.
Putri CA. Manajemen Nyeri Neuropati Pada Pasien Diabetes Melitus Tipe 2. Jurnal Medika Hutama. 2021;2(3):954-958.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
